Comparative Profiling of Cytosolic Accumulation of Cell-Penetrating Peptides in Mammalian and Bacterial Cells
En palabras de los autores
Delivering molecules to the cytosol remains a major bottleneck in antibacterial therapy, as both the Gram-negative bacterial envelope and host-cell membranes restrict intracellular access. Cell-penetrating peptides (CPPs) offer a potential strategy for overcoming these barriers. However, selecting CPPs for conjugate development remains largely empirical, in part because conventional fluorescence-based uptake measurements can misidnentify cellular association as cytosolic delivery. Here, we used our recently developed Chloroalkane Azide-tagged Membrane Permeation (CHAMP) assay, a HaloTag-based flow cytometry platform that directly reports cytosolic arrival, to systematically compare 40 CPPs in mammalian cells and Escherichia coli (E. coli). In mammalian cells, cytosolic accumulation varied substantially within each peptide class, indicating that uptake depends on individual sequence features rather than class membership alone. Among peptides with measurable accumulation in both systems, none exhibited greater apparent accumulation in mammalian cells than in E. coli. Complementary assays showed that several peptides reached the bacterial cytosol without detectable membrane damage, whereas others accumulated in association with compromised membrane integrity. Together, these findings provide a quantitative comparison of CPP-mediated cytosolic access in mammalian and bacterial cells and establish a framework for selecting peptide carriers for antibiotic conjugates.
Apareció: martes, 17 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.